263 related articles for article (PubMed ID: 15788001)
21. Neutrophil serine proteases exert proteolytic activity on endothelial cells.
Jerke U; Hernandez DP; Beaudette P; Korkmaz B; Dittmar G; Kettritz R
Kidney Int; 2015 Oct; 88(4):764-75. PubMed ID: 26061547
[TBL] [Abstract][Full Text] [Related]
22. Selective proteolytic cleavage of IL-2 receptor and IL-6 receptor ligand binding chains by neutrophil-derived serine proteases at foci of inflammation.
Bank U; Reinhold D; Schneemilch C; Kunz D; Synowitz HJ; Ansorge S
J Interferon Cytokine Res; 1999 Nov; 19(11):1277-87. PubMed ID: 10574621
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic potential of human elafin.
Shaw L; Wiedow O
Biochem Soc Trans; 2011 Oct; 39(5):1450-4. PubMed ID: 21936832
[TBL] [Abstract][Full Text] [Related]
24. Reddish, scaly, and itchy: how proteases and their inhibitors contribute to inflammatory skin diseases.
Meyer-Hoffert U
Arch Immunol Ther Exp (Warsz); 2009; 57(5):345-54. PubMed ID: 19688185
[TBL] [Abstract][Full Text] [Related]
25. Activation, apoptosis, and clearance of neutrophils in Wegener's granulomatosis.
van Rossum AP; Limburg PC; Kallenberg CG
Ann N Y Acad Sci; 2005 Jun; 1051():1-11. PubMed ID: 16126939
[TBL] [Abstract][Full Text] [Related]
26. German cockroach frass proteases cleave pro-matrix metalloproteinase-9.
Hughes VS; Page K
Exp Lung Res; 2007; 33(3-4):135-50. PubMed ID: 17558676
[TBL] [Abstract][Full Text] [Related]
27. Inactivation of interleukin-6 by neutrophil proteases at sites of inflammation. Protective effects of soluble IL-6 receptor chains.
Bank U; Küpper B; Ansorge S
Adv Exp Med Biol; 2000; 477():431-7. PubMed ID: 10849768
[TBL] [Abstract][Full Text] [Related]
28. Protease-activated receptors: protease signaling in the gastrointestinal tract.
Amadesi S; Bunnett N
Curr Opin Pharmacol; 2004 Dec; 4(6):551-6. PubMed ID: 15525542
[TBL] [Abstract][Full Text] [Related]
29. Elafin and its precursor trappin-2 still inhibit neutrophil serine proteinases when they are covalently bound to extracellular matrix proteins by tissue transglutaminase.
Guyot N; Zani ML; Maurel MC; Dallet-Choisy S; Moreau T
Biochemistry; 2005 Nov; 44(47):15610-8. PubMed ID: 16300411
[TBL] [Abstract][Full Text] [Related]
30. Tumor necrosis factor-alpha (TNF-alpha) induces integrin CD11b/CD18 (Mac-1) up-regulation and migration to the CC chemokine CCL3 (MIP-1alpha) on human neutrophils through defined signalling pathways.
Montecucco F; Steffens S; Burger F; Da Costa A; Bianchi G; Bertolotto M; Mach F; Dallegri F; Ottonello L
Cell Signal; 2008 Mar; 20(3):557-68. PubMed ID: 18164590
[TBL] [Abstract][Full Text] [Related]
31. Tailor-made inflammation: how neutrophil serine proteases modulate the inflammatory response.
Kessenbrock K; Dau T; Jenne DE
J Mol Med (Berl); 2011 Jan; 89(1):23-8. PubMed ID: 20809089
[TBL] [Abstract][Full Text] [Related]
32. Protease-activated receptors: how proteases signal to cells to cause inflammation and pain.
Bunnett NW
Semin Thromb Hemost; 2006 Apr; 32 Suppl 1():39-48. PubMed ID: 16673265
[TBL] [Abstract][Full Text] [Related]
33. Inhibitors of serine proteases as potential therapeutic agents: the road from thrombin to tryptase to cathepsin G.
Maryanoff BE
J Med Chem; 2004 Feb; 47(4):769-87. PubMed ID: 14761180
[No Abstract] [Full Text] [Related]
34. Prolonged pharmacological inhibition of cathepsin C results in elimination of neutrophil serine proteases.
Guarino C; Hamon Y; Croix C; Lamort AS; Dallet-Choisy S; Marchand-Adam S; Lesner A; Baranek T; Viaud-Massuard MC; Lauritzen C; Pedersen J; Heuzé-Vourc'h N; Si-Tahar M; Fıratlı E; Jenne DE; Gauthier F; Horwitz MS; Borregaard N; Korkmaz B
Biochem Pharmacol; 2017 May; 131():52-67. PubMed ID: 28193451
[TBL] [Abstract][Full Text] [Related]
35. Serine proteases, their inhibitors and allergy.
Smith PK; Harper JI
Allergy; 2006 Dec; 61(12):1441-7. PubMed ID: 17073875
[TBL] [Abstract][Full Text] [Related]
36. Effect of E. faecalis on the release of serine proteases elastase and cathepsin G, and collagenase-2 (MMP-8) by human polymorphonuclear leukocytes (PMNs).
Reynaud af Geijersstam A; Sorsa T; Stackelberg S; Tervahartiala T; Haapasalo M
Int Endod J; 2005 Sep; 38(9):667-77. PubMed ID: 16104981
[TBL] [Abstract][Full Text] [Related]
37. N-terminal proteolytic processing by cathepsin G converts RANTES/CCL5 and related analogs into a truncated 4-68 variant.
Lim JK; Lu W; Hartley O; DeVico AL
J Leukoc Biol; 2006 Dec; 80(6):1395-404. PubMed ID: 16963625
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of novel phosphonic-type activity-based probes for neutrophil serine proteases and their application in spleen lysates of different organisms.
Grzywa R; Burchacka E; Łęcka M; Winiarski Ł; Walczak M; Łupicka-Słowik A; Wysocka M; Burster T; Bobrek K; Csencsits-Smith K; Lesner A; Sieńczyk M
Chembiochem; 2014 Nov; 15(17):2605-12. PubMed ID: 25236966
[TBL] [Abstract][Full Text] [Related]
39. Protease-activated receptors as drug targets in inflammation and pain.
Vergnolle N
Pharmacol Ther; 2009 Sep; 123(3):292-309. PubMed ID: 19481569
[TBL] [Abstract][Full Text] [Related]
40. Signalling pathways mediating inflammatory responses in brain ischaemia.
Planas AM; Gorina R; Chamorro A
Biochem Soc Trans; 2006 Dec; 34(Pt 6):1267-70. PubMed ID: 17073799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
